Last reviewed · How we verify
NCT03535129
A Response Modulation Hypothesis of Socioemotional Processing Associated With Alcohol Use Disorder
NA trial testing Real time fMRI neurofeedback in Healthy Volunteers in 104 participants. Completed in 23 March 2025.
23 March 2025
Quick facts
| Lead sponsor | National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 104 |
| Start date | 20 September 2018 |
| Primary completion | 23 March 2025 |
| Estimated completion | 23 March 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Real time fMRI neurofeedback
Conditions studied
- Healthy Volunteers — all drugs for Healthy Volunteers →
- Alcohol Drinking Related Problems — all drugs for Alcohol Drinking Related Problems →
- Alcohol-Related Disorders — all drugs for Alcohol-Related Disorders →
Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Who can join
Adults 21 to 65, any sex, with Healthy Volunteers or Alcohol Drinking Related Problems. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: Problem drinking affects nearly half the people who drink alcohol. Drinking alcohol affects a person s social behavior and brain structure, but researchers don t have a good understanding of how. They want to test a technique called neurofeedback to learn more about how to treat problem drinking. Objectives: To study what happens in the brains of people who drink alcohol when they look at pictures of social things and of alcohol. To learn if people can control brain activity in a magnetic resonance imaging (MRI) scanner and if this helps people with drinking. Eligibility: Adults ages 21 65 who have an alcohol use disorder. Healthy volunteers ages 21 65 Design: Participants will be screened with Physical exam Medical history Blood, urine, and heart tests Mental health interview Questions about their alcohol drinking. At each session, participants will have: A urine test for drugs and pregnancy. If they test positive, they cannot participate. A breath alcohol test and assessment for alcohol withdrawal. Participants will complete surveys, talk to researchers about behaviors, and play games. Participants will have MRI brain scans. The scanner is a metal cylinder in a strong magnetic field. They will lie on a table that slides in and out of the scanner for 1 2 hours. Participants will do tasks in the scanner: They will look at pictures, sometimes of alcohol. They will try to hit a goal. Some participants will get feedback during this task. They will see how their brain activity changes or how someone else s changes. Participants may have follow-up phone questions at least 3 times over about 6 months.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Selecting an optimal real-time fMRI neurofeedback method for alcohol craving control training.
Fede SJ, Kisner MA, Dean SF, Kerich M, et al · · 2023 · cited 4× · PMID 37326428 · DOI 10.1111/psyp.14367 -
Alcohol attention bias modulates neural engagement during moral processing.
Fede SJ, Kisner MA, Dean SF, Buckler E, et al · · 2024 · PMID 39038485 · DOI 10.1080/17470919.2024.2377666
Verify or expand the search:
- PubMed search for NCT03535129
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy Volunteers
Currently open trials in the same condition.
- NCT07504003 — Influence of Training Session Duration on Improvements in Physiological Resilience to Exercise · NA · recruiting
- NCT07446400 — A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuva · Phase 1 · recruiting
- NCT07495813 — A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease · Phase 1 · recruiting
- NCT07499050 — A Study of Multiple Doses of Orally Administered RO7795081 in Otherwise Healthy Chinese Adult Participants With Obesity · Phase 1 · recruiting
- NCT07342114 — A Dose-Escalation Study of RO7875913 in Healthy Participants · Phase 1 · recruiting
Other National Institute on Alcohol Abuse and Alcoholism (NIAAA) trials
Trials by the same sponsor.
- NCT07325266 — Human Laboratory Study of Apremilast for Alcohol Use Disorder · Phase 2 · recruiting
- NCT07046819 — Tirzepatide in MetALD · Phase 2 · recruiting
- NCT06819189 — Role of Metal Ion Transporter ZIP8 in Alcohol-Related Behaviors · Phase 1 · recruiting
- NCT06269627 — Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder · Phase 4 · recruiting
- NCT06484075 — Suvorexant for Alcohol Use Disorder (AUD): Neural Mechanisms · Phase 1, PHASE2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03535129 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Last refreshed: 4 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03535129.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing